ICD-10 Code C86.11 | Hepatosplenic T-cell lymphoma, in remission Symptoms, Diagnosis, Billing

Hepatosplenic T-cell lymphoma is a rare type of non-Hodgkin lymphoma characterized by the proliferation of T-cells in the liver and spleen. It typically occurs in immunocompromised individuals and can lead to significant morbidity. The ICD-10 Code C86.11 is essential for accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively track and manage this condition.

What is ICD-10 Code C86.11 for Hepatosplenic T-cell lymphoma, in remission?

ICD-10 Code C86.11 represents Hepatosplenic T-cell lymphoma, in remission, indicating that the disease has responded to treatment and is currently not active. This code should be used when documenting patients who have a confirmed diagnosis of this lymphoma type and are in a state of remission, facilitating appropriate clinical documentation and billing processes.

ICD-10 Code C86.11 – Clinical Definition and Explanation of Hepatosplenic T-cell lymphoma, in remission

Hepatosplenic T-cell lymphoma, in remission, is a hematological malignancy that arises from the clonal proliferation of T-lymphocytes, primarily affecting the liver and spleen. It is often associated with immunosuppression and can lead to severe complications if not monitored. Medical attention is crucial for ongoing management and surveillance.

Key Clinical Features:

• Typically presents with splenomegaly and hepatomegaly.
• May cause cytopenias due to bone marrow infiltration.
• Often associated with immunocompromised states, such as HIV or post-transplant.
• Diagnosis confirmed through biopsy and immunophenotyping.

ICD-10 Code C86.11 for Hepatosplenic T-cell lymphoma, in remission – SOAP Notes & Clinical Use

ICD-10 Code C86.11 is utilized in SOAP notes to document the patient's remission status, guiding clinical assessments and treatment plans. It plays a vital role in both acute and chronic care settings, ensuring comprehensive documentation of the patient's health status and treatment outcomes.

What Does ICD-10 Code C86.11 for Hepatosplenic T-cell lymphoma, in remission Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C86.11 connects subjective patient reports and objective clinical findings to a formal diagnosis of Hepatosplenic T-cell lymphoma, in remission. This code is crucial for maintaining continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code C86.11 – Hepatosplenic T-cell lymphoma, in remission

Management of Hepatosplenic T-cell lymphoma, in remission, focuses on monitoring and supportive care to prevent relapse. Treatment strategies may include chemotherapy and immunotherapy, tailored to the patient's specific needs.

Antibiotic Therapy:

• Not typically indicated unless there is an infection; consider prophylactic antibiotics in immunocompromised patients.
• First-line: Trimethoprim-sulfamethoxazole for Pneumocystis jirovecii pneumonia prophylaxis.
• Alternative: Azythromycin for atypical infections.

Supportive Care:

• Regular monitoring of blood counts and liver function tests.
• Management of symptoms such as fatigue and pain.
• Nutritional support and counseling.

Infection Control:

• Strict hand hygiene and infection control measures.
• Avoid exposure to infectious agents, especially in immunocompromised patients.
• Vaccination against preventable diseases as appropriate.

How to Document Symptoms of Hepatosplenic T-cell lymphoma, in remission (ICD-10 C86.11) in SOAP Notes

Subjective:

• Patient reports feeling well with no new symptoms.
• Denies fever, night sweats, or weight loss.
• History of splenomegaly noted during previous evaluations.

Objective:

• Physical examination reveals no hepatosplenomegaly.
• Blood tests show stable complete blood count.
• Imaging studies indicate no signs of active disease.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Hepatosplenic T-cell lymphoma, in remission (ICD-10 Code C86.11)

Assessment:

• Diagnosis: Hepatosplenic T-cell lymphoma, in remission.
• ICD-10 Code: C86.11.
• No current symptoms or signs of active disease.

Plan:

• Continue regular follow-up appointments every 3-6 months.
• Monitor blood counts and liver function tests.
• Educate patient on signs of relapse and when to seek care.

Treatment & Plan Section for ICD-10 Code C86.11 – Hepatosplenic T-cell lymphoma, in remission

• Consider ongoing surveillance with imaging and laboratory tests.
• Encourage a healthy lifestyle to support immune function.
• Provide education on potential late effects of treatment.
• Schedule follow-up visits to monitor for recurrence.

Using ICD-10 Code C86.11 for Hepatosplenic T-cell lymphoma, in remission in Billing & SOAP Note Compliance

• Ensure accurate documentation of remission status in patient records.
• Use C86.11 in conjunction with relevant CPT codes for billing.
• Document all clinical findings and treatment plans to support claims.
• Review coding guidelines to ensure compliance with payer requirements.

Related ICD-10 Codes Often Used with Hepatosplenic T-cell lymphoma, in remission

• C85.90 – Non-Hodgkin lymphoma, unspecified
• C82.90 – Follicular lymphoma, unspecified, in remission

ICD-10 Code C86.11 in Medical Billing and Insurance for Hepatosplenic T-cell lymphoma, in remission

ICD-10 Code C86.11 is critical in medical billing, particularly in hospital, ER, or infectious disease care settings, ensuring accurate representation of the patient's condition.

Billing Notes:

• Document all relevant clinical findings to support the use of C86.11.
• Use this code in conjunction with treatment codes for comprehensive billing.
• Ensure that the patient's remission status is clearly noted in the medical record.

Common CPT Pairings: